Hepatitis C Care That Comes to You — No Insurance, No Cost, No Judgment
If you live in Nashville, Davidson County, or anywhere in Middle Tennessee and have been putting off a Hepatitis C test — because of cost, because you’re not sure where to go, or because the idea feels overwhelming — this page is for you. LifeLine Health Tennessee provides confidential Hepatitis C testing and treatment through telehealth, at no cost, to any Tennessee resident regardless of insurance status or ability to pay. You do not need to travel to a clinic. You do not need to pay anything upfront. And you will not be judged for why you’re getting tested.
LifeLine Health does not currently operate a physical clinic in Nashville. All services for Middle Tennessee residents are delivered via telehealth — a secure video or phone appointment you can join from home, a parked car, or anywhere private. That structure is intentional. For many people, it removes the biggest barriers: transportation, time off work, and the discomfort of sitting in a waiting room.
What Hepatitis C Actually Is
Hepatitis C is a viral infection that targets the liver. The virus — called HCV, short for Hepatitis C virus — spreads through blood-to-blood contact. Over time, without treatment, HCV can cause liver inflammation, scarring (fibrosis), cirrhosis, and in some cases liver cancer or liver failure [source:1]. What makes it particularly difficult to catch early is that most people have no symptoms for years, sometimes decades.
The Centers for Disease Control and Prevention estimates that approximately 2.4 million people in the United States are living with Hepatitis C, and a significant portion don’t know it [source:2]. That’s not because people are careless — it’s because the virus is quiet. Many people only find out through routine screening or when a doctor investigates something unrelated.
How HCV Spreads
The most common route of transmission in the U.S. today is sharing needles, syringes, or other equipment used to inject drugs — even a single shared use carries risk [source:1]. Other routes include:
- Needlestick injuries in healthcare settings
- Being born to a mother who has Hepatitis C
- Sharing personal items that may carry blood, such as razors or glucose monitors
- Receiving a blood transfusion or organ transplant before 1992, when screening became standard
Sexual transmission of HCV is less common but does occur, particularly among people with HIV or those who have multiple partners with certain sexual practices that may involve blood exposure [source:1]. HCV does not spread through casual contact — hugging, sharing food, coughing, or breastfeeding (unless nipples are cracked and bleeding).
Who Should Get Tested — and How Often
The U.S. Preventive Services Task Force recommends Hepatitis C screening for all adults aged 18 to 79, at least once in their lifetime [source:3]. For people with ongoing risk factors — such as current or past injection drug use — repeat testing is recommended more frequently, often annually [source:2].
You may also want to consider testing if you:
- Were born between 1945 and 1965 (the “Baby Boomer” generation had significantly higher rates of HCV exposure)
- Have ever shared any injection equipment, even once, even years ago
- Are pregnant — the CDC recommends testing during each pregnancy [source:2]
- Have HIV, since HCV co-infection is common and affects treatment decisions
Getting tested once doesn’t mean you’re covered forever if risk factors continue. Reinfection after successful treatment is possible, which is why ongoing testing matters for people with active exposures.
The Testing Process: From Antibody Screen to Diagnosis
Hepatitis C testing happens in two stages, and understanding the difference helps reduce confusion about results.
Step One: The Antibody Test
The first test checks your blood for HCV antibodies — proteins your immune system produces in response to the virus. A positive antibody result means your body has encountered HCV at some point. It does not automatically mean you currently have an active infection [source:1]. After a successful treatment or in rare cases of spontaneous clearance, antibodies remain in the blood for life.
Step Two: The RNA Test
If your antibody test comes back positive, the next step is an HCV RNA test (sometimes called a viral load test). This test looks directly for the virus’s genetic material in your blood. A positive RNA result confirms an active infection. A negative RNA result after a positive antibody test generally means the infection has cleared — either through treatment or on its own [source:1].
At LifeLine Health Tennessee, our care team walks you through both steps and explains what your results mean in plain language. You won’t be handed a number and left to search the internet.
What Happens After a Positive Diagnosis
A positive HCV RNA result is the beginning of a process, not the end of a road. Before starting treatment, a clinical evaluation helps the care team understand your liver health and overall situation. This typically includes:
- A review of your medical history and any current medications
- Liver function tests to assess how the liver is performing
- A FIB-4 score or similar non-invasive assessment to estimate liver fibrosis (scarring) without a biopsy
- Genotype testing to identify which strain of HCV you have — there are six main genotypes, and treatment selection can depend on this
This evaluation shapes the treatment plan. It also helps identify whether any liver damage has already occurred and needs monitoring alongside treatment.
Direct-Acting Antiviral Treatment: What It Is and What to Expect
Hepatitis C is curable. That sentence still surprises many people, because for decades it wasn’t. The development of direct-acting antivirals (DAAs) changed that. These are oral medications — pills, taken once daily — that work by targeting specific proteins the HCV virus needs to replicate [source:4].
Current DAA regimens typically run 8 to 12 weeks, depending on the genotype, the degree of liver damage, and whether you’ve had prior treatment [source:4]. Most people experience few or no significant side effects compared to older interferon-based treatments, which were notoriously difficult to tolerate.
What “Cured” Means Clinically
Cure in the context of Hepatitis C has a specific clinical definition: sustained virologic response at 12 weeks post-treatment, or SVR12. This means the virus is undetectable in your blood 12 weeks after finishing treatment [source:4]. SVR12 is considered a cure because relapse after this point is rare. Achieving SVR12 also significantly reduces the risk of liver-related complications, including cirrhosis progression and liver cancer — though it does not reverse existing severe scarring [source:5].
LifeLine Health cannot guarantee a specific outcome for any individual, because treatment response depends on factors unique to each person. What we can say is that modern DAA therapy achieves SVR rates above 95% in most patient populations in clinical studies [source:4].
Support During Treatment
Treatment isn’t just a prescription. The LifeLine Health team stays in contact throughout your treatment course — answering questions, checking in on how you’re feeling, and addressing any concerns that come up. If you’re navigating addiction alongside HCV, that’s something we understand and can work with, not around. People who use drugs can and do successfully complete Hepatitis C treatment.
Follow-Up Testing After Treatment
After you finish your medication course, a follow-up RNA test at the 12-week mark confirms whether SVR12 has been achieved. If the virus is undetectable, treatment was successful. If there’s still detectable virus, the care team will discuss next steps — which may include a different regimen or additional evaluation.
Following successful treatment, HCV antibodies remain in your blood permanently. This means a future antibody test will still come back positive, which can cause confusion. An RNA test is always needed to determine whether an active infection is present after treatment.
Preventing Reinfection
Clearing HCV does not make you immune. Reinfection is possible if exposure to the virus continues [source:1]. Prevention after treatment focuses on the same strategies that reduce initial transmission risk:
- Using new, sterile needles and syringes for every injection
- Accessing syringe service programs, which are available in several Tennessee communities
- Not sharing any drug preparation equipment, including cookers, cotton, or water
- Using barrier protection during sex in contexts where blood exposure may occur
Discussing reinfection risk isn’t about judgment — it’s about giving you the information to protect the health you’ve worked to recover. Our team approaches these conversations without shame and without assumptions.
Getting Care from Nashville Without Leaving Home
Nashville is a city where a lot of people are stretched thin. Long commutes, unpredictable work schedules, childcare responsibilities, and limited access to reliable transportation are real barriers — not excuses. Telehealth removes most of them.
To access LifeLine Health’s Hepatitis C testing and treatment services, Nashville residents start by completing a secure intake form online. From there, a care coordinator connects with you to arrange lab work at a location convenient to you and schedule your telehealth appointment. You don’t need a smartphone with a camera for every step — phone-only options are available for parts of the process.
For people who have avoided healthcare in the past because of previous negative experiences — being dismissed, judged, or treated poorly — the telehealth model also offers a degree of control. You’re in your own space. You set the pace of the conversation.
Privacy and Confidentiality
All services through LifeLine Health Tennessee are confidential. Your test results and medical information are protected under federal health privacy law (HIPAA). We do not share your information with employers, family members, or anyone else without your explicit consent.
For people concerned about stigma — whether related to a history of drug use, sexual behavior, or simply the diagnosis itself — confidentiality is not a small thing. It’s often the deciding factor in whether someone seeks care at all. We take it seriously.
Cost and Insurance: The Straightforward Answer
LifeLine Health’s Hepatitis C testing and treatment services cost nothing to you. No copay, no bill after the fact, no sliding scale that still leaves you with a balance. This applies whether you have insurance, Medicaid, Medicare, or no coverage at all. The organization is specifically structured to serve people who fall through the gaps of the traditional healthcare system.
If you do have insurance, we may bill it on your behalf — but you will never be charged the difference, and having insurance is not required to receive care.
Common Misconceptions About Hepatitis C
A few persistent myths keep people from getting tested or treated. It’s worth addressing them directly.
“I would know if I had it.” Most people with chronic Hepatitis C have no symptoms until the infection has caused significant liver damage — which can take 20 to 30 years [source:1]. Feeling healthy is not the same as testing negative.
“It only affects people who use drugs.” Injection drug use is the most common transmission route in the U.S. today, but HCV has affected people across every demographic. Baby Boomers, for instance, have rates of infection roughly five times higher than other adults — largely from exposures before blood screening was standard [source:2].
“Treatment is too hard.” This was true of older interferon-based regimens, which caused severe fatigue, depression, and flu-like symptoms. Modern DAA therapy is taken as a daily pill and is generally well-tolerated [source:4].
“I can’t get treatment if I’m still using drugs.” Active drug use is not a barrier to Hepatitis C treatment at LifeLine Health. Research supports treating HCV in people who use drugs, and doing so can actually support broader health improvements [source:5].
Frequently Asked Questions
How long does the whole process take from first contact to starting treatment?
It varies depending on lab turnaround times and scheduling, but many people move from initial intake to starting treatment within a few weeks. The care team will give you a realistic timeline based on your specific situation.
Do I need to come into an office at any point?
Lab work requires a blood draw, which is done at an external lab location. The clinical consultations — reviewing results, discussing treatment, follow-up care — happen via telehealth. The team works to identify lab options accessible to you.
What if I’ve been treated for Hepatitis C before and it didn’t work?
Prior treatment history is part of the evaluation process. There are DAA regimens specifically designed for people who did not achieve SVR with a previous course of treatment. This is something to discuss directly with the care team.
Can I get tested even if I don’t think I have Hepatitis C?
Yes. Screening is recommended for all adults 18–79 regardless of perceived risk [source:3]. Many people who test positive had no reason to suspect it.
What if I have other health conditions or take other medications?
Drug interactions are a real consideration with some DAA regimens. The clinical team reviews your full medication list before recommending a treatment plan. This is part of why the evaluation step matters.
Taking the First Step — From Wherever You Are
If you’re in Nashville, Antioch, Brentwood, Murfreesboro, or anywhere else in Middle Tennessee, the path to Hepatitis C care doesn’t require a clinic visit or a day off work. It starts with a conversation.
LifeLine Health Tennessee’s Hepatitis C testing and treatment program is built for people who have real lives and real barriers. No-cost care. Telehealth delivery. A team that meets you where you are — without judgment about where that is.
When you’re ready, reach out to us through our secure contact form. A care coordinator will follow up to explain the next steps and answer any questions you have before committing to anything. There’s no pressure and no obligation — just a starting point.